TransMedics Group, Inc.
TMDX
$133.81
-$8.12-5.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 566.35M | 531.29M | 488.23M | 441.54M | 401.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 566.35M | 531.29M | 488.23M | 441.54M | 401.09M |
| Cost of Revenue | 224.95M | 213.62M | 197.88M | 179.46M | 163.10M |
| Gross Profit | 341.41M | 317.68M | 290.35M | 262.08M | 237.99M |
| SG&A Expenses | 180.63M | 177.27M | 176.08M | 168.62M | 154.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 470.40M | 454.72M | 435.71M | 404.04M | 367.64M |
| Operating Income | 95.95M | 76.58M | 52.52M | 37.50M | 33.46M |
| Income Before Tax | 92.88M | 74.09M | 50.06M | 35.78M | 32.65M |
| Income Tax Expenses | 1.11M | 2.43M | 1.11M | 316.00K | 16.00K |
| Earnings from Continuing Operations | 91.77 | 71.66 | 48.95 | 35.46 | 32.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.77M | 71.66M | 48.95M | 35.46M | 32.64M |
| EBIT | 95.95M | 76.58M | 52.52M | 37.50M | 33.46M |
| EBITDA | 120.55M | 100.30M | 74.11M | 57.25M | 51.14M |
| EPS Basic | 2.71 | 2.12 | 1.46 | 1.07 | 0.99 |
| Normalized Basic EPS | 1.71 | 1.37 | 0.93 | 0.68 | 0.66 |
| EPS Diluted | 2.48 | 1.94 | 1.37 | 1.02 | 0.93 |
| Normalized Diluted EPS | 1.45 | 1.17 | 0.83 | 0.64 | 0.62 |
| Average Basic Shares Outstanding | 135.34M | 134.67M | 133.87M | 132.91M | 131.97M |
| Average Diluted Shares Outstanding | 156.43M | 151.37M | 146.10M | 140.86M | 139.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |